11:15 EDT UroGen Pharma trading resumes Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See the top stocks recommended by analysts >> Read More on URGN: UroGen Pharma’s Promising Trial Results and FDA Progress UroGen Pharma announces David Lin as chief commercial officer UroGen Pharma price target lowered to $32 from $34 at Oppenheimer UroGen Pharma trading resumes UroGen Pharma trading halted, volatility trading pause Questions or Comments about the article? Write to editor@tipranks.com